Prominent Vessel Signs After Endovascular Thrombectomy Corelates with Unexplained Neurological Deterioration and is a More Reliable Imaging Predictor of Prognosis in Anterior Large Vessel Occlusion Stroke

医学 磁共振成像 优势比 冲程(发动机) 置信区间 磁化率加权成像 闭塞 放射科 内科学 心脏病学 机械工程 工程类
作者
Xiaoli Fu,Jianxia Ke,Jintao Li,Kefeng Lv,Junting Chen,Jingrui Li,Weicheng Zheng,Zhu Shi
出处
期刊:World Neurosurgery [Elsevier BV]
卷期号:179: e201-e211
标识
DOI:10.1016/j.wneu.2023.08.052
摘要

Fifty percent of patients who undergo endovascular thrombectomy (EVT) for large-vessel occlusion exhibit unfavorable outcomes. The primary factor is attributed to persistent brain impairment even after successful EVT. The prominent vessel sign (PVS) on magnetic resonance susceptibility-weighted imaging reflects the territory of dysmetabolism and may facilitate an expeditious assessment for prognostication. We aimed to examine the relationship between PVS after EVT and the occurrence of early neurological deterioration (END) and 3-month outcomes. Patients who underwent EVT and multimodal magnetic resonance imaging were included. END was defined as an increase of ≥2 in the National Institutes of Health Stroke Scale within 72 hours after EVT. Symptomatic intracranial hemorrhage, malignant edema, and surgical complications were defined as definite END, whereas the other symptoms were categorized as unexplained END (ux-END). The PVS-Alberta Stroke Program Early CT Score (ASPECTS) score was used to evaluate the asymmetric cerebral venous signal on the susceptibility-weighted imaging sequences semiquantitatively. A total of 116 eligible patients were included, 18 (15.5%) of whom presented with ux-END. The 72 hour National Institutes of Health Stroke Scale was strongly correlated with diffusion-weighted imaging infarct volume and PVS-ASPECTS and was significantly higher in the ux-END group (16 ± 6 vs. 5 ± 4, P = 0.001). The PVS-ASPECTS score was significantly associated with poor outcomes (odds ratio 2.551, 95% confidence interval (CI) 1.722–3.780, P<0.001), and PVS-ASPECTS (area under the curve 0.884, 95% CI 0.815–0.953, P < 0.001) was superior to diffusion-weighted imaging infarct volume (area under the cure 0.720, 95% CI 0.620–0.820, P = 0.001) in predicting 3-month poor outcome. At the optimal cut-off of 2, the PVS-ASPECT predicted poor outcomes with a sensitivity of 89.7% and a specificity of 78.2%. PVS 72 hours after EVT correlated with ux-END. The PVS-ASPECTS is a more reliable predictor of stroke prognosis and provides valuable information regarding post-EVT management.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
乐观的翠琴完成签到 ,获得积分10
刚刚
拉长的诗蕊完成签到,获得积分10
3秒前
wuqs完成签到,获得积分10
3秒前
张平一完成签到 ,获得积分10
3秒前
Monroe完成签到 ,获得积分10
19秒前
jjy完成签到,获得积分10
21秒前
gloval完成签到,获得积分10
21秒前
CodeCraft应助甜叶菊采纳,获得10
26秒前
敬老院N号应助guoxingliu采纳,获得200
27秒前
Gaolongzhen完成签到 ,获得积分10
28秒前
沧海一粟米完成签到 ,获得积分10
35秒前
36秒前
不渡江完成签到,获得积分20
38秒前
clock完成签到 ,获得积分10
48秒前
春花完成签到,获得积分10
51秒前
Twonej应助不渡江采纳,获得30
52秒前
woshiwuziq完成签到 ,获得积分0
1分钟前
疯狂的巨蟹完成签到,获得积分10
1分钟前
小呵点完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
六沉完成签到 ,获得积分10
1分钟前
allen1994完成签到,获得积分10
1分钟前
orixero应助科研通管家采纳,获得10
1分钟前
忧虑的安青完成签到,获得积分10
1分钟前
我要看文献完成签到 ,获得积分10
1分钟前
端庄洪纲完成签到 ,获得积分10
1分钟前
stiger完成签到,获得积分0
1分钟前
甜心椰奶莓莓完成签到 ,获得积分10
1分钟前
AAA完成签到,获得积分10
1分钟前
丰富的德天完成签到 ,获得积分10
1分钟前
先锋老刘001完成签到,获得积分10
1分钟前
又又完成签到,获得积分10
2分钟前
喜乐完成签到 ,获得积分10
2分钟前
guoxingliu完成签到,获得积分10
2分钟前
xingqing完成签到 ,获得积分10
2分钟前
笨笨忘幽完成签到,获得积分0
2分钟前
栗子完成签到,获得积分10
2分钟前
聪慧的若山完成签到,获得积分10
2分钟前
CLTTT完成签到,获得积分0
2分钟前
高分求助中
Adhesion Science: Principles & Practice 1234
Signals, Systems, and Signal Processing 610
Inflectional Morphology in Harmonic Serialism 600
Competition Law: Cases and Materials, 5th edition 500
Petrology and Plate Tectonics,2025 400
Burger's Medicinal Chemistry and Drug Discovery 400
A Step-by-Step Guide to Qualitative Data Coding 2nd Edition 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6711218
求助须知:如何正确求助?哪些是违规求助? 8450524
关于积分的说明 18042687
捐赠科研通 5956657
什么是DOI,文献DOI怎么找? 2992963
邀请新用户注册赠送积分活动 1968892
关于科研通互助平台的介绍 1918274